Evaluating the Impact of a Value-based Prescription Drug Formulary

Completed

Conditions studied: Value-Based Health Insurance

In brief

The objective of this study is to evaluate the impact of the value-based formulary on patient out-of-pocket spending and health plan spending as well as the impact of the value-based formulary on medication use, emergency department visits, hospitalizations, and outpatient office visits.

Key facts

Study ID

NCT04904055

Run by

Kaiser Permanente

People needed

36333

Starts

2015-01-01

Expected to finish

2019-12-31

Last updated by the study team

2021-05-27

Who can join

Age: any, up to 64. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Individuals:
• aged 0-64
• Continuously enrolled in an employer-sponsored health plan for at least 12 months (with one-month allowable gap) prior to the index date
• For individuals in the exposed group, the index date is defined as the start date of value-based formulary implementation at the employer group level
• For individuals in the control group, the index date is defined as the index date of the matched exposed individual
• Employer groups:
• that transition to the value-based formulary if they transitioned all enrollees in that employer group (no individual selection)

You may not qualify if…

• Individuals with:
• missing gender information
• missing zip code level demographics at all member months

Where it is running

• Kaiser Permanente — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.